tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
:SVNS
UK Market
Advertisement

Solvonis Therapeutics (SVNS) Income Statement

Compare
10 Followers

Solvonis Therapeutics Income Statement

Last quarter (Q4 2024), Solvonis Therapeutics's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Solvonis Therapeutics's net income was £-335.00K. See Solvonis Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 587.00K£ 542.00K£ 219.00K£ 690.86K£ 330.00K
Gross Profit
£ -134.00K£ -51.00K£ 55.00K£ 517.72K£ 284.00K
Operating Expenses
£ 3.26M£ 2.66M£ 900.00K£ 629.14K£ 748.00K
Depreciation and Amortization
£ 177.00K£ 113.00K£ 46.00K£ 121.71K£ 114.00K
EBITDA
£ -2.94M£ -2.59M£ -900.00K£ -322.29K£ -352.00K
Operating Income
£ -3.12M£ -2.71M£ -845.00K£ -111.43K£ -352.00K
Other Income/Expenses
£ -3.00K£ -4.00K£ -109.00K£ -162.86K£ -72.00K
Pretax Income
£ -3.12M£ -2.71M£ -954.00K£ -274.29K£ -538.00K
Net Income
£ -3.12M£ -2.71M£ -954.00K£ -274.29K£ -538.00K
Per Share Metrics
Basic EPS
£ -0.03£ -0.03£ -0.01£ 0.00£ -0.01
Diluted EPS
£ -0.03£ -0.03£ -0.01£ 0.00£ -0.01
Weighted Average Shares Outstanding
104.06M 103.59M 104.10M 104.10M 104.10M
Weighted Average Shares Outstanding (Diluted)
104.06M 103.59M 104.10M 104.10M 104.10M
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis